share_log

康龙化成(300759.SZ)股东信中康成拟减持不超1066.67万股

In the shareholder letter of PHARMARON (300759.SZ), it is proposed that Kangcheng intends to reduce its Shareholding by no more than 10.6667 million shares.

Zhitong Finance ·  Dec 26 03:43

PHARMARON (300759.SZ) announced that the company recently received a notice from a shareholder holding over 5% of shares, Shenzhen Xinchungang Cheng...

According to the Zhiyun Finance APP, PHARMARON (300759.SZ) announced that it recently received a "Shareholding Reduction Plan Notice" from its 5% or more Shareholder, Shenzhen Xinchungangcheng Investment Partnership (Limited Partnership) (referred to as "Xinchungangcheng") and its concerted actor, Shenzhen Xinchunlongcheng Investment Partnership (Limited Partnership) (referred to as "Xinchunlongcheng"). Xinchungangcheng plans to reduce its shares of the company by no more than 10.6667 million shares (accounting for 0.60% of the company's total share capital) through concentrated bidding transactions or block trades or other legally recognized methods by the Shenzhen Exchange, within two months after 15 trading days from the date of disclosure of this announcement (January 20, 2025).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment